Could mRNA vaccines be the next big thing for melanoma?
Academic rigour, journalistic flair
Articles on Immunotherapy
Displaying 1 - 20 of 52 articles
Until now, chemo and radiation therapy have been main cancer treatments but they can also damage healthy tissues. Immunotherapy uses the body’s immune system to fight cancer with minimal harm
Melanoma is the deadliest form of skin cancer.
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
Honey has long been used as a natural remedy for many ailments.
T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.
This study further highlights the potential of mRNA vaccines in cancer treatment.
Sublingual immunotherapy reduces hay fever symptoms by changing the immune system’s response to allergens.
From cancer immunotherapy and antibiotics to GMO crops and pandemic surveillance, gain of function is a cornerstone of basic research.
There is no one-size-fits-all approach to treating cancer. Understanding how cancer cells evolve could help researchers develop more effective drugs.
Cancer vaccines are an emerging personalised treatment for cancer. Using the same mRNA technology as COVID vaccines, they stimulate the immune system to destroy cancer cells.
Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
New research has found that a parasite first identified in dogs could help stimulate the human immune system to attack cells of cancerous tumours.
October is awash in seas of pink T-shirts, balloons and ribbons in honor of Breast Cancer Awareness Month. But this messaging fails to recognize people who are not cured of the disease.
It’s a long-term treatment – people having allergen immunotherapy typically notice improved symptoms after six to 12 months.
Patients with blood cancer undergoing stem cell transplantation have a high risk of complications. The bacteria in their gut, however, can help their immune system recover and fight infections.
Pioneered by the Human Cell Atlas consortium, our understanding of the human body is about to be transformed – and with it, the way we treat and prevent disease
One promising cancer treatment has been in the works for decades, but severe side effects have kept it out of the clinic. A reengineered version may offer a way to safely harness its potent effects.
Applying the principles of ecology and evolution could help oncologists anticipate cancer drug resistance and optimize their treatment plans for patients.
Top contributors
-
Professor of Biomedical Sciences, Anglia Ruskin University
-
Associate Professor & Head of Projects, York St John University
-
Associate Pro Vice-Chancellor: Innovation and Knowledge Exchange, York St John University
-
Postdoctoral research scientist, Columbia University
-
Oncologist and Senior Lecturer, University of Newcastle
-
Professor of Sociology, Ball State University
-
Professor of Neurosurgery, University of Florida
-
Professor of Experimental Medicine, University of Southampton
-
Director of Drug Discovery at MRC Technology and Honorary Professor, Queen Mary University of London
-
Senior Research Fellow, University of Technology Sydney
-
CRUK Senior Lecturer Head and Neck Surgery, University of Southampton
-
Associate Professor in Cancer Immunology, University of Southampton
-
Assistant Professor, Georgia State University
-
University of Florida
-
Professor and Director - Academic Excellence, Macquarie University
